Panacea: Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

Panacea Life Sciences Holdings, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 1.06 million compared to USD 0.677481 million a year ago. Net loss was USD 1.45 million compared to USD 1.79 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.12 a year ago. Diluted loss per share from continuing operations was USD 0.09 compared to USD 0.12 a year ago.